Advertisement

Central hemodynamic effects of oxytocin and interaction with magnesium and pregnancy in the isolated perfused rat heart

      Abstract

      OBJECTIVE: Our purpose was to determine the cardiac effects of oxytocin in the isolated perfused rat heart model and to see whether pregnancy or pharmacologic levels of magnesium modifies the hormone's action. STUDY DESIGN: Hearts were excised from 30 female Sprague-Dawley rats (15 pregnant, 15 nonpregnant) and attached to a Langendorf's apparatus. Heart rate, left ventricular systolic pressure, and contractility were measured. Hearts were exposed serially to 2, 4, and 6 mU/ml concentrations of oxytocin. The experiment was repeated in 15 pregnant animals at a magnesium level of 5 mEq/L. RESULTS: Hearts from pregnant rats had lower heart rates than did hearts from nonpregnant animals. Oxytocin exposure diminished heart rate but increased left ventricular systolic pressure and contractility in a dose-dependent manner. Pregnancy did not alter this response. Magnesium levels of 5 mEq/L reversed the effects of oxytocin on contractility and left ventricular systolic pressure. CONCLUSION: Oxytocin is a negative chronotropic and positive inotropic agent in hearts from pregnant and nonpregnant rats. Magnesium reserves the positive inotropic effects of oxytocin. (Am J Obstet Gynecol 1997;177:91-3)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hendricks CH
        • Brenner WE.
        Cardiovascular effects of oxytocic drugs used post partum.
        Am J Obstet Gynecol. 1970; 108: 751-754
        • Secher NJ
        • Amso P
        • Wallin L.
        Haemodynamic effects of oxytocin (syntocinon) and methylergometrial (Methergin) on the systemic and pulmonary circulations of pregnant anesthesized women.
        Acta Obstet Gynecol Scand. 1978; 57: 97-107
        • Bieniarz J.
        Pharmacology of oxytocin.
        in: Oxytocin. Pergamon Press, New York1961: 80-83
        • Padayachi T
        • Norman JR
        • Dhavavaj K
        • Kemp M
        • Joubert SM.
        Serial oxytocin levels in amniotic fluid and maternal plasma during normal and induced labor.
        Br J Obstet Gynaecol. 1988; 95: 888-893
        • Phaneuf S
        • Asboth G
        • MacKenzie LZ
        • Melin P
        • Lopez Bernal A.
        Effect of oxytocin antagonists on the activation of human myometrium in vitro: atosiban prevents oxytocin-induced desensitization.
        Am J Obstet Gynecol. 1994; 171: 1627-1633
        • Fallin EL
        • Elliot WL
        • Goulin G.
        Apparatus for study of ventricular function and metabolism in the isolated, perfused rat heart.
        J Appl Physiol. 1967; 22: 836-839
        • Thorp Jr, JM
        • Spielman FJ
        • Valea FA
        • Payne FG
        • Mueller RA
        • Cefalo RC.
        Nifedipine enhances the cardiac toxicity of magnesium sulfate in the isolated perfused Sprague-Dawley rat heart.
        Am J Obstet Gynecol. 1990; 163: 655-656
        • Goodwin TM
        • Millar L
        • North L
        • Abrans LS
        • Weglein RC
        • Holland ML.
        The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions.
        Am J Obstet Gynecol. 1995; 173: 913-917